September 24, 2024- With few exceptions, the race of procedures to the lowest-acuity setting shows no signs of letting up. Statistics indicate the ambulatory surgery market is big and getting bigger. But reimbursement issues, legislation and shifting ownership patterns will no doubt shape the outcome.
“We anticipate a variety of increasing surgical procedures to shift to outpatient,” says Jason Grzyb, vice president, non-acute sales for Cardinal Health’s U.S. Medical Products and Distribution business. “As ASCs continue to be met with complexities like evolving regulatory compliance, new technology advancements, supply chain management and more, we’re still seeing significant growth and expansion within the industry. ASCs are providing a convenient, cost-effective alternative for surgical procedures – while still delivering safe, quality care in a highly competitive market.”
According to Fortune Business Insights, the U.S. ambulatory surgical center market size was valued at $43.70 billion in 2022 and is projected to grow to $75.20 billion by 2030. In terms of ownership, the physician-owned segment accounted for the largest market share in 2022, while the corporate-owned segment was anticipated to record the highest compound annual growth rate (CAGR) during the forecast period of 2023-2030.
Read more in the latest issue of JHC.